Literature DB >> 11594060

Comparison of photosensitizer (AIPcS2) quantification techniques: in situ fluorescence microsampling versus tissue chemical extraction.

C C Lee1, B W Pouge, R R Strawbridge, K L Moodie, L R Bartholomew, G C Burke, P J Hoopes.   

Abstract

A noninvasive in situ fluorescence-based method for the quantification of the photosensitizer chloroaluminum disulfonated phthalocyanine was compared to the highly accurate but nonreal time ex vivo spectrofluorometry method. Our in vivo fluorescence technique is designed to allow real-time assessment of photosensitizer in tumor and normal tissues and therefore temporally optimal light delivery. Laser-induced fluorescence was used to measure photosensitizer concentration from multiple microscopic regions of tissue. Ex vivo chemical extraction was used to quantify photosensitizer concentration in the same volume of tissue. The amount of photosensitizer in the vascular and/or parenchymal compartments of skeletal muscle and liver was determined by quantifying fluorescent signal in vivo, ex vivo and after blood removal. Confocal microscopy was used to spatially document photosensitizer localization 30 min and 24 h after delivery. While a linear correlation can exist between the fluorescence intensity measured by our fiber-optic bundle system and actual tissue concentration, temporal changes to this calibration line exist as the photosensitizer changes its partitioning fraction between the blood (vasculature) and the tissue parenchyma. In situ photosensitizer fluorescence microsampling (dosimetry) systems can be performed in real time and linearly correlated to actual tissue concentration with minimal intertissue variance. Tissue-specific differences may require temporal alterations in the calibration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594060     DOI: 10.1562/0031-8655(2001)074<0453:copaqt>2.0.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  5 in total

1.  Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.

Authors:  Srivalleesha Mallidi; Sriram Anbil; Seonkyung Lee; Dieter Manstein; Stefan Elrington; Garuna Kositratna; David Schoenfeld; Brian Pogue; Steven J Davis; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2014-02       Impact factor: 3.170

2.  Protoporphyrin IX fluorescence photobleaching increases with the use of fractionated irradiation in the esophagus.

Authors:  Brian W Pogue; Chao Sheng; Juan Benevides; David Forcione; Bill Puricelli; Norm Nishioka; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2008 May-Jun       Impact factor: 3.170

3.  Vitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study.

Authors:  Edward V Maytin; Golara Honari; Amor Khachemoune; Charles R Taylor; Bernhard Ortel; Brian W Pogue; Nathaniel Sznycer-Taub; Tayyaba Hasan
Journal:  Isr J Chem       Date:  2012-08-21       Impact factor: 3.333

4.  Semi-empirical model of the effect of scattering on single fiber fluorescence intensity measured on a turbid medium.

Authors:  S C Kanick; D J Robinson; H J C M Sterenborg; A Amelink
Journal:  Biomed Opt Express       Date:  2011-12-14       Impact factor: 3.732

5.  Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.

Authors:  S Andrejevic Blant; T M Glanzmann; J-P Ballini; G Wagnières; H van den Bergh; P Monnier
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.